RESUMO
The purpose of this study was to investigate whether differences in the pattern of the lingual plate split in sagittal split ramus osteotomy (SSRO) affect the remodelling of the split site. Sixty-one patients with mandibular prognathism (122 sides) underwent SSRO. Computed tomography (CT) was performed at 1 week and 1 year after SSRO. Bone splits were classified according to the lingual split scale (LSS) and the lateral bone cut end (LBCE) by evaluating CT images at 1 week. The remodelling at the split sites was evaluated by superimposing the CT images obtained at 1 week and 1 year. Regarding the LSS pattern, significant differences were observed in the distance between anteroposterior ramus points (P = 0.033) and the ramus area in the axial image (P = 0.011). The LBCE pattern also showed a significant difference in the distance between anteroposterior ramus points (P = 0.043). In conclusion, the differences in the lingual plate split and ramus cut end of the SSRO influence the postoperative remodelling in the anteroposterior region of the split site.
Assuntos
Má Oclusão Classe III de Angle , Prognatismo , Placas Ósseas , Humanos , Mandíbula/cirurgia , Osteotomia Sagital do Ramo Mandibular/métodos , Prognatismo/diagnóstico por imagem , Prognatismo/cirurgiaRESUMO
Resorbable materials are used to fix bony fragments after sagittal split ramus osteotomy (SSRO), but to our knowledge, there is no clear regimen for antibiotic prophylaxis when such materials are used. The purpose of this study therefore was to compare inpatient single-agent and extended dual-agent antibiotic prophylaxis for the prevention of surgical site infections (SSI) in patients after SSRO. This prospective study included 100 patients who underwent SSRO for deformities of the jaw. Cephalometric analysis was performed preoperatively, and at one month and one year postoperatively. Patients were divided into two groups of 50 each. Group A was given cefazolin sodium 1g preoperatively and every eight hours for 48 hours postoperatively. Group B was given cefazolin sodium 1g preoperatively and every eight hours for 48 hours postoperatively, after which they were provided with oral amoxicillin for three days. Both groups were assessed for SSIs for one year postoperatively using the Clavien-Dindo classification. SSIs were documented in seven patients in Group A and six in Group B, with no significant difference between the groups. The two regimens had no significant association with SSI. In conclusion, our results suggest that the inpatient, single-agent, postoperative antibiotic regimen is sufficient to prevent SSI in patients who have SSRO with resorbable plate and screw fixation.
Assuntos
Osteotomia Sagital do Ramo Mandibular , Prognatismo , Antibioticoprofilaxia , Parafusos Ósseos , Humanos , Pacientes Internados , Mandíbula , Estudos ProspectivosRESUMO
Essentials How thrombocytopenia relates to bleeding in 22q11 deletion syndrome (22q11DS) is not clear. Bleeding severity, platelet count and volume, and GPIBB were examined in patients with 22q11DS. Macrothrombocytopenia and bleeding typified imperfectly overlapping subsets of 22q11DS patients. GPIBB hemizygosity does not cause macrothrombocytopenia or bleeding in patients with 22q11DS. SUMMARY: Background and objectives Macrothrombocytopenia and bleeding are frequently associated with 22q11 deletion syndrome (22q11DS). GPIBB, which encodes the glycoprotein (GP) Ibß subunit of GPIb-IX-V, is commonly deleted in patients with 22q11DS. Absence of functional GPIb-IX-V causes Bernard-Soulier syndrome, which is a severe bleeding disorder characterized by macrothrombocytopenia. Patients with 22q11DS are often obligate hemizygotes for GPIBB, and those with only a pathogenically disrupted copy of GPIBB present with Bernard-Soulier syndrome. The objective of this study was to determine how GPIBB hemizygosity and sequence variation relate to macrothrombocytopenia and bleeding in patients with 22q11DS who do not have Bernard-Soulier syndrome. Patients/methods We thoroughly characterized bleeding severity, mean platelet volume, platelet count and GPIBB copy number and sequence in patients with 22q11DS. Results and conclusions Macrothrombocytopenia and mild bleeding were observed in incompletely overlapping subsets of patients, and GPIBB copy number and sequence variation did not correlate with either macrothrombocytopenia or bleeding in patients with 22q11DS. These findings indicate that GPIBB hemizygosity does not result in either macrothrombocytopenia or bleeding in these patients. Alternative genetic causes of macrothrombocytopenia, potential causes of acquired thrombocytopenia and bleeding and ways in which platelet size, platelet count and GPIBB sequence information can be used to aid in the diagnosis and management of patients with 22q11DS are discussed.
Assuntos
Síndrome da Deleção 22q11/genética , Síndrome de Bernard-Soulier/genética , Hemizigoto , Hemorragia/genética , Hemostasia/genética , Complexo Glicoproteico GPIb-IX de Plaquetas/genética , Trombocitopenia/genética , Síndrome da Deleção 22q11/sangue , Síndrome da Deleção 22q11/diagnóstico , Adolescente , Síndrome de Bernard-Soulier/sangue , Síndrome de Bernard-Soulier/diagnóstico , Criança , Pré-Escolar , Feminino , Dosagem de Genes , Predisposição Genética para Doença , Hemorragia/sangue , Hemorragia/diagnóstico , Humanos , Masculino , Volume Plaquetário Médio , Repetições Minissatélites , Fenótipo , Contagem de Plaquetas , Polimorfismo de Nucleotídeo Único , Fatores de Risco , Análise de Sequência de DNA , Trombocitopenia/sangue , Trombocitopenia/diagnósticoRESUMO
The purpose of this study was to compare computed tomography (CT) Hounsfield unit values of bone fragment gaps after sagittal split ramus osteotomy (SSRO) in patients with and without asymmetry, and to evaluate differences between the deviated and non-deviated sides in asymmetric patients. Thirty-two patients who underwent a bilateral SSRO were included in this retrospective study. Patients were divided into symmetric and asymmetric groups by cephalometric analysis. CT values of the bone fragment gap were measured at 1 week and at 1 year after surgery. There were significant differences between CT values obtained at 1 week and at 1 year after surgery for all measurement points. However, there were no significant differences in CT values between symmetric and asymmetric patients at either 1 week or 1 year after surgery. Among asymmetric patients, there were no significant differences between the deviated and non-deviated sides at 1 week or 1 year after surgery. This study showed ossification of the bone fragments and adaptation to change the mandible form in patients with and without asymmetry following SSRO.
Assuntos
Assimetria Facial/diagnóstico por imagem , Osteotomia Sagital do Ramo Mandibular , Prognatismo/diagnóstico por imagem , Adolescente , Adulto , Cefalometria , Assimetria Facial/cirurgia , Feminino , Humanos , Masculino , Má Oclusão Classe III de Angle , Mandíbula/diagnóstico por imagem , Pessoa de Meia-Idade , Prognatismo/cirurgia , Estudos Retrospectivos , Fatores de Tempo , Tomografia Computadorizada por Raios X , Adulto JovemRESUMO
BACKGROUND: The C-type lectin-like receptor 2 (CLEC-2) and the collagen receptor glycoprotein (GP)VI activate platelets through Src and Syk tyrosine kinases, and phospholipase Cγ2. The initial events in the two signaling cascades, however, are distinct, and there are quantitative differences in the roles of proteins downstream of Syk activation. The activation of Akt and mitogen-activated protein kinases (MAPKs) has been shown to enhance platelet activation by GPVI, but their role in CLEC-2 signaling is not known. OBJECTIVES: We sought to investigate the role of the Akt and MAPK pathways in platelet activation by CLEC-2. RESULTS: The CLEC-2 agonist rhodocytin stimulated phosphorylation of Akt and p38 and extracellular signal-related kinase (ERK) MAPKs, but with a delay relative to Syk. Phosphorylation of these proteins was markedly inhibited in the combined presence of apyrase and indomethacin, consistent with the reported feedback action of ADP and thromboxane A2 in CLEC-2 signaling. Phosphorylation of Akt and phosphorylation of ERK were blocked by the phosphoinositide 3-kinase (PI3K) inhibitor wortmannin and the protein kinase C (PKC) inhibitor Ro31-8220, respectively, whereas Syk phosphorylation was not altered. On the other hand, both inhibitors reduced phosphorylation of the Akt substrate glycogen synthase kinase 3α/ß (GSK3α/ß). Phosphorylation of GSK3α/ß was also blocked by the Akt inhibitor MK2206, and reduced at late, but not early, times by the MEK inhibitor PD0325901. MK2206 and PD0325901 inhibited aggregation and secretion in response to a low concentration of rhodocytin, which was restored by GSK3α/ß inhibitors. CONCLUSIONS: These results demonstrate that CLEC-2 regulates Akt and MAPK downstream of PI3K and PKC, leading to phosphorylation and inhibition of GSK3α/ß, and enhanced platelet aggregation and secretion.
Assuntos
Plaquetas/efeitos dos fármacos , MAP Quinases Reguladas por Sinal Extracelular/metabolismo , Quinase 3 da Glicogênio Sintase/metabolismo , Lectinas Tipo C/agonistas , Glicoproteínas de Membrana/agonistas , Agregação Plaquetária/efeitos dos fármacos , Proteínas Proto-Oncogênicas c-akt/metabolismo , Venenos de Víboras/farmacologia , Plaquetas/enzimologia , Relação Dose-Resposta a Droga , Ativação Enzimática , MAP Quinases Reguladas por Sinal Extracelular/antagonistas & inibidores , Glicogênio Sintase Quinase 3 beta , Humanos , Peptídeos e Proteínas de Sinalização Intracelular/metabolismo , Lectinas Tipo C/metabolismo , Glicoproteínas de Membrana/metabolismo , Fosforilação , Proteína Quinase C/antagonistas & inibidores , Proteína Quinase C/metabolismo , Inibidores de Proteínas Quinases/farmacologia , Proteínas Tirosina Quinases/metabolismo , Proteínas Proto-Oncogênicas c-akt/antagonistas & inibidores , Transdução de Sinais/efeitos dos fármacos , Quinase Syk , Fatores de TempoRESUMO
The purpose of this retrospective study was to evaluate the changes in computed tomography (CT) values of ramus bone and screws after sagittal split ramus osteotomy (SSRO) setback surgery. The subjects were 64 patients (128 sides) who underwent bilateral SSRO setback surgery. They were divided into six groups according to the fixation plate type used and the use or not of self-setting α-tricalcium phosphate (Biopex): group 1: titanium plate and screws; group 2: titanium plate and screws with Biopex; group 3: poly-l-lactic acid (PLLA) plate and screws; group 4: PLLA plate and screws with Biopex; group 5: uncalcined and unsintered hydroxyapatite particles and poly-l-lactic acid (uHA/PLLA) plate and screws; group 6: PLLA/uHA plate and screws with Biopex. CT values (pixel values) of the lateral cortex, medial cortex, osteotomy site, and screws were measured preoperatively, immediately after surgery, and 1 year postoperatively using horizontal CT images at the mandibular foramen taken parallel to the Frankfort horizontal plane. There were significant differences in the time-course change of pixel values for the lateral cortex (P<0.0001) and the osteotomy site (P<0.0001) among the six groups. This study suggests that the fixation plate type and use of bone alternative material may affect bone quality during the process of bone healing after SSRO.
Assuntos
Osteotomia Sagital do Ramo Mandibular , Prognatismo/diagnóstico por imagem , Prognatismo/cirurgia , Tomografia Computadorizada por Raios X/métodos , Adolescente , Adulto , Materiais Biocompatíveis , Placas Ósseas , Parafusos Ósseos , Cefalometria , Humanos , Japão , Pessoa de Meia-Idade , Interpretação de Imagem Radiográfica Assistida por Computador , Estudos Retrospectivos , Titânio , Resultado do TratamentoRESUMO
This study aimed to evaluate the postoperative changes in masticatory function in patients with jaw deformities with or without asymmetry treated by orthognathic surgery. Thirty female patients who underwent a Le Fort I osteotomy with sagittal split ramus osteotomy (SSRO) were enrolled. The patients were divided into symmetry and asymmetry groups. The bite force, occlusal contact area, and bite force balance were measured before and at 1, 3, and 6 months and 1 year after surgery; these measurements were compared statistically within and between the two groups. In the symmetry group, there was a significant difference in the preoperative bite force and the 1 month postoperative bite force (P=0.0033). In the asymmetry group, the bite force before surgery was significantly different from that at 1 month (P=0.0375) and at 1 year (P=0.0353) after surgery. Significant differences in the bite force were also observed between the following time points: 1 month and 1 year (P=0.0003), 3 months and 1 year (P=0.0034), and 1 month and 6 months (P=0.0486). The occlusal contact area, bite force, and occlusal balance tended to change after Le Fort I osteotomy with SSRO, with a significantly improved bite force in patients with asymmetry before surgery.
Assuntos
Assimetria Facial/fisiopatologia , Mastigação/fisiologia , Cirurgia Ortognática , Prognatismo/cirurgia , Adolescente , Adulto , Força de Mordida , Cefalometria , Oclusão Dentária , Feminino , Humanos , Pessoa de Meia-Idade , Osteotomia de Le Fort , Osteotomia Sagital do Ramo Mandibular , Estudos Retrospectivos , Resultado do TratamentoRESUMO
The purpose of this study was to examine the changes in border movement of the mandible before and after mandibular ramus osteotomy in patients with prognathism. The subjects were 73 patients with mandibular prognathism who underwent sagittal split ramus osteotomy (SSRO) with and without Le Fort I osteotomy. Border movement of the mandible was recorded with a mandibular movement measure system (K7) preoperatively and at 6 months postoperatively. Of the 73 patients, 21 had measurements taken at 1.5 years postoperative. Data were compared between the pre- and postoperative states, and the differences analyzed statistically. There was no significant difference between SSRO alone and SSRO with Le Fort I osteotomy in the time-course change. The values at 6 months postoperative were significantly lower than the preoperative values for maximum vertical opening (P=0.0066), maximum antero-posterior movement from the centric occlusion (P=0.0425), and centric occlusion to maximum opening (P=0.0300). However, there were no significant differences between the preoperative and 1.5 years postoperative measurements. This study suggests that a postoperative temporary reduction in the border movement of the mandible could recover by 1.5 years postoperative, and the additional procedure of a Le Fort I osteotomy does not affect the recovery of mandibular motion after SSRO.
Assuntos
Má Oclusão Classe III de Angle/fisiopatologia , Má Oclusão Classe III de Angle/cirurgia , Mandíbula/fisiopatologia , Mandíbula/cirurgia , Procedimentos Cirúrgicos Ortognáticos , Adulto , Feminino , Humanos , Masculino , Movimento/fisiologia , Osteotomia Sagital do Ramo Mandibular , Resultado do TratamentoRESUMO
The purpose of this study was to compare retrospectively postoperative differences in maxillary stability after Le Fort I osteotomy and fixation with an unsintered hydroxyapatite (u-HA)/poly-l-lactic acid (PLLA) plate with or without self-setting α-tricalcium phosphate (Biopex(®)) as interpositional material. Subjects comprised 45 patients diagnosed with mandibular prognathism with maxillary retrognathism and mandibular prognathism with bimaxillary asymmetry. All patients underwent Le Fort I osteotomy and bilateral sagittal split ramus osteotomy with fixation by uHA/PLLA plates. Patients were divided into 4 groups consisting of 9 maxillary impaction cases with Biopex(®) (group 1) to fill the gap between the bone segments, 14 maxillary advancement cases with Biopex(®) (group 2), 8 maxillary impaction cases without Biopex(®) (group 3) and 14 maxillary advancement cases without Biopex(®) (group 4). Changes in cepahalometric parameters at time intervals (1, 3 and 12 months) between the groups were compared. Results showed that stability did not depend on the use or otherwise of Biopex(®).
Assuntos
Implantes Absorvíveis , Materiais Biocompatíveis/uso terapêutico , Cimentos Ósseos/uso terapêutico , Placas Ósseas , Fosfatos de Cálcio/uso terapêutico , Durapatita/química , Maxila/patologia , Osteotomia de Le Fort/métodos , Poliésteres/química , Adolescente , Adulto , Materiais Biocompatíveis/química , Cefalometria/métodos , Sulfatos de Condroitina/uso terapêutico , Assimetria Facial/cirurgia , Feminino , Seguimentos , Humanos , Hidroxiapatitas/uso terapêutico , Incisivo/patologia , Técnicas de Fixação da Arcada Osseodentária/instrumentação , Masculino , Mandíbula/cirurgia , Maxila/cirurgia , Pessoa de Meia-Idade , Osso Nasal/patologia , Osteotomia de Le Fort/instrumentação , Osteotomia Sagital do Ramo Mandibular/métodos , Prognatismo/cirurgia , Estudos Retrospectivos , Sela Túrcica/patologia , Succinatos/uso terapêutico , Adulto JovemRESUMO
The purpose of this study was to examine the changes in lip pressure before and after orthognathic surgery for skeletal class III patients. The subject groups were 32 female and 31 male patients diagnosed with mandibular prognathism and/or maxillary retrognathism who underwent orthognathic surgery. Control groups consisted of 20 women and 20 men with normal occlusion without dento-alveolar deformity. Maximum and minimum lip closing force was measured with Lip De Cum® for the control groups and subject groups preoperatively and 6 months postoperatively. The difference between the pre- and postoperative values of the groups was examined statistically. The maximum lip closing force in men was significantly larger than that in women in both the preoperative class III group (p=0.0330) and the control group (p=0.0097). The preoperative class III group was significantly smaller than the control group in maximum lip closing force in both men (p<0.0001) and women (p<0.0001). The postoperative maximum lip closing force was significantly larger than the preoperative value in both men (p=0.0037) and women (p=0.0273) in the Class III group. This study suggested that the maximum lip closing force increases after orthognathic surgery in Class III patients.
Assuntos
Lábio/fisiopatologia , Má Oclusão Classe III de Angle/fisiopatologia , Procedimentos Cirúrgicos Ortognáticos/métodos , Adulto , Cefalometria/métodos , Feminino , Seguimentos , Humanos , Processamento de Imagem Assistida por Computador/métodos , Masculino , Má Oclusão Classe III de Angle/cirurgia , Osteotomia Mandibular/métodos , Maxila/anormalidades , Maxila/cirurgia , Osteotomia de Le Fort/métodos , Osteotomia Sagital do Ramo Mandibular/métodos , Pressão , Prognatismo/fisiopatologia , Prognatismo/cirurgia , Fatores Sexuais , Estresse MecânicoRESUMO
The purpose of this study was to compare postoperative changes in maxillary stability after Le Fort I osteotomy in three groups: with an unsintered hydroxyapatite (u-HA)/poly-L-lactic acid (PLLA) plate; a PLLA plate; and a titanium plate. Subjects comprised 60 Japanese patients diagnosed with mandibular prognathism. All patients underwent Le Fort I osteotomy and bilateral sagittal split ramus osteotomy. All patients were randomized in groups of 20 to a u-HA/PLLA group, a PLLA plate group and a titanium plate group. Changes in postoperative time intervals between the plate groups were compared using lateral and posteroanterior cephalography. The uHA/PLLA group had significantly larger values than the PLLA group regarding change of mx1-S perpendicular to SN between 3 and 12 months (T3) (P=0.0269). The uHA/PLLA group had a significantly larger value than the PLLA group regarding change of S-A perpendicular to SN between baseline and 1 month (T1) (P=0.0257). There was no significant difference in the other measurements. This study suggests that maxillary stability with satisfactory results could be obtained in the u-HA/PLLA, PLLA plate and titanium plate groups, although there was a slight difference between the u-HA/PLLA and PLLA plate systems in Le Fort I osteotomy.
Assuntos
Materiais Biocompatíveis/classificação , Placas Ósseas/classificação , Maxila/cirurgia , Osteotomia de Le Fort/instrumentação , Adolescente , Adulto , Materiais Biocompatíveis/química , Parafusos Ósseos , Cefalometria/métodos , Queixo/patologia , Durapatita/química , Feminino , Seguimentos , Humanos , Incisivo/patologia , Técnicas de Fixação da Arcada Osseodentária , Ácido Láctico/química , Masculino , Maxila/patologia , Pessoa de Meia-Idade , Dente Molar/patologia , Osso Nasal/patologia , Procedimentos Cirúrgicos Ortognáticos/instrumentação , Osteotomia Sagital do Ramo Mandibular/métodos , Poliésteres/química , Polímeros/química , Prognatismo/cirurgia , Estudos Prospectivos , Sela Túrcica/patologia , Titânio/química , Adulto Jovem , Zigoma/patologiaRESUMO
We examined survival in 53 patients over 60 years old who had chronic obstructive pulmonary disease, and whose FEV1 was less than 60% of the forced vital capacity and was less than 60% of the predicted value. They comprised 34 men and 19 women. The mean age was 75.2 years. The %FEV1 was 39.0% and the body mass index was 19.0. Neither age %FEV1, nor body mass index differed significantly between men and women. However, the number of cigarettes smoked per day, the number of years of cigarette smoking, and the Brinkman index were higher in men than in women. The Brinkman index was 1255.0 in men and 617.8 in women (p = 0.0001). For the group as a whole, the 5-year survival rate was 65% and the 10-year survival rate was 35%. The survival rate of men did not differ from that of women. Survival and %FEV1 did not differ between men and women, despite the significant difference in Brinkman index, which suggests that women were more susceptible to the effects of cigarette smoking than men. Age, one tenth of %FEV1, and body mass index less than 19 were found to be independent predictors of mortality (proportional hazards analysis, p = 0.044, 0.019, and 0.024, respectively). The 5-year survival rate were as follows: 85% in patients less than 75 years of age, 50% in patients more than 75 years of age, 25% in patients with a %EFV1 less than 30%, 80% in patients with a %FEV1 of 30% to 49%, 62% in patients with a %FEV1 of 50% to 60%, 50% in patients with a body mass index of less than 19, and 83% in patients with a body mass index of more than 19.